2025 fourth_quarter Filing
Q4Expenses
$100K
Method: A
Filed
January 26, 2026
Lobbying Activities
Government IssuesView all
Issues related to the reorganization of HHS and its underlying agencies: NIH, CDC, CMS, and FDA; impact of executive order on NIH indirect costs and what it means for the institution and the biomedical research space as a whole; the future of ARPA-H; federal grant terminations; the future of global health programs;
Contacted:HOUSE OF REPRESENTATIVES, SENATE
Medical/Disease Research/Clinical LabsView all
Issues related to clinical trial design and patients obtaining drugs sooner in the course of the trial
Contacted:Food & Drug Administration (FDA)
Lobbyists (1)
EDWARD MILLER